The CAROLYN Trial: Lisocabtagene Maraleucel as First-Line Therapy for Primary Central Nervous System Lymphoma (PCNSL) in Transplant-Ineligible Patients
Why this Research Matters
Research Studies help doctors and researchers to find new and better ways to understand, detect, control, and treat illness. Research is how scientists and other professionals obtain information to answer questions that they hope will benefit society.
Who can Participate
Adult
Study ID
Protocol Number: 25-1099
More information available at ClinicalTrials.gov: NCT07015242
Meet the Team
Principal Investigator